Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (922)	4/5/2000 11:15:00 PM
From: Jim Oravetz	Read Replies (1) \| Respond to of 52153

This is a rear view mirror shot at Vanguard Health Care Fund holdings as of 1/31/00. Sorry for the format NOT! Biotech Research & Production(3.20%) Shares MktCap. IDEC Pharmaceuticals Corp. IDPH 1,325,000 167,198 Human Genome Sciences, Inc. HGSI 873,000 85,554 Quintiles Transnatiorial Corp. QTRN 2,037,200 53,858 IDEXX Laboratories Corp. IDXX 70,000 16,117 Cephalon, Inc. CEPH 290,000 10,295 Drugs & Pharmaceuticals (37.50%) Immunex Corp. IMNX 4,770,200 623,704 Genzyme Corp. GENZ 3,027,920 157,452 Gilead Sciences, Inc. GILD 2,012,481 94,209 Vertex Pharmaceuticals, Inc VTRX 1,927,700 79,036 Pharmacyclics, Inc. PCYC 738,000 36,946 Forest Laboratories, Inc. . FRX 326,400 22,032 Cor Therapeutics, Inc. CORR 530,000 14,045 Triangle Pharmaceuticals, Inc. VIRS 564,800 11,084 Magainin Pharmaceuticals, Inc. MAGN 1,328,100 3,984 BioCryst Pharmaceuticals, Inc. BCRX 151,400 3,189 Scios, Inc. SCIO 491,750 2,551 International Pharmaceuticals (22.3%) Japan- 10% UK - 6.9% Nycomed Amersham PLC 12,565,820 79,180 Oxford GlycoSciences PLC 375,000 5,045 Celltech Group 98,000 1,308 Other-5.4%